Official.

On Wednesday the FDA granted Emergency Use Authorization to a third booster dose at least 6 months after previous Pfizer vaccination for all those who are 65+ years of age as well as those 18+ years with risk of either serious disease (e.g., due to medical comorbidities) or frequent exposure (e.g., certain healthcare workers or institutionalized persons). | FDA 2021